Home » Clinical Trials » Search Clinical Trials
Parent Therapeutic Areas: Oncology
Solid Tumors
Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals
A Phase I Safety and Pharmacokinetic Study of IT-101 in the Treatment of Advanced Solid Tumors
A Phase I Trial of PS-341 in Combination with Topotecan in Advanced Solid Tumor Malignancies
A Phase I, Multi-Center, Open Label Dosimetry Study of I-131-CLR1404 in Patients with Relapsed or Refractory Advanced Solid Tumors who have Failed Standard Therapy or for Whom No Standard Therapy Exists
A Prospective, Randomized Trial Comparing the Efficacy of Anidulafungin and Voriconazole in Combination to that of Voriconazole Alone When Used for Primary Therapy of Proven or Probable Invasive Aspergillosis
COG ACCRN07: Protocol for the Enrollment on the Official COG Registry, the Childhood Cancer Research Network (CCRN) for Groupwide Participation
COG ALTE03N1: Key Adverse Events After Childhood Cancer
Dasatinib with Ifosfamide, Carboplatin, Etoposide: A Pediatric Phase I/II Trial
Evaluation of BCL-XL Specific Immunity
Innovative Underserved Community-Based Cancer Risk Screening
Passport for Care: Implementation in Multiple Institutions
Phase I study of I-131-CLR1404 in patients with Relapsed or Refractory Advanced Solid Tumors
Phase I Trial of Intraperitoneal nab-Paclitaxel (Abraxane) in the Treatment of Advanced Malignancies Primarily Confined to the Peritoneal Cavity
Phase I/II Study of a Triplet Combination of CBP501, Pemetrexed and Cisplatin in Patients with Advanced Solid Tumors and in Chemotherapy-Naive Patients with Malignant Pleural Mesothelioma
PHI-53 NCI#7251: A Phase I Trial of PXD101 in Combination with 13-cis-Retinoic Acid in Advanced Solid Tumor Malignancies
PHI-54 NCI #7540: Phase I Trial of Intravenous Fenretinide (4-HPR) for Patients with Malignant Solid Tumors
PHI-55 NCI#7427: A Phase I Study of Halichondrin B Analog (E7389) in Combination with Cisplatin in Advanced Solid Tumors
PHI-60 NCI#8063: A Phase I and Pharmacokinetic Single Agent Study of Pazopanib in Patients with Advanced Malignancies and Varying Degrees of Liver Dysfunction
PHI-61 NCI#7967: A Phase I Study of ABT-888 in Combination with Carboplatin and Paclitaxel in Advanced Solid Malignancies
PHI-62: NCI# 8275: A Phase I Study of ABT-888 in Combination with Metronomic Cyclophosphamide in Adults with Refractory Solid Tumors and Lymphomas
Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals
A Phase 1 Study of Bavituximab in Patients with Solid Tumors
A Phase 1 Study of S-1 Administered in Combination with Taxotere
A Phase 1 Study of STA-9090, Administered Once-Weekly in Patients with Solid Tumors
A Phase 2 Study of ARQ 197 in Patients with Microphthalmia Transciption Factor Associated Tumors
A Phase I Dose Finding Study of TRC105 in Patients with Advanced or Metastatic Solid Cancer
A Phase I Dose-Escalation Study of SCH900776 as Monotherapy and in Combination with Gemcitabine in Subjects with Advanced Solid Tumors or Lymphoma
A Phase I Study of AMG 479 in Combination with either Nexavar or Erlotinib
A Phase I Study of ARQ 197 in Combination with Tarceva in Patients with Advanced Solid Tumors
A Phase I Study of Asonep in Subjects with Refractory Advanced Solid Tumors
A Phase I Study of BIIB015 in Patients with Cripto-Positive Solid Tumors
A Phase I Study of BIIB021 Administered Once or Twice Daily to Subjects with Advanced Solid Tumors
A Phase I Study of CP751,871 + Sutent in Patients with Advanced Solid Tumors
A Phase I Study of IPI-493 in Patients with Advanced Malignancies
A Phase I Study of MP470 in Combination with Standard of Care Chemotherapy Regimens
A Phase I Study of SSR244738 (TED5799) in Patients with Refractory Solid Tumors
A Phase I Study of the HSP90 Inhibitor STA-9090 in Patients with Solid Tumors
A Phase I Study of TRC102 in Combination with Alimta in Patients with Advanced Solid Tumors
A Phase I Study of XL518 in Subjects with Advanced Solid Tumors
A Phase I Trial of CVX-060, an Anti-Angiogenic COVX-BODY in Patients with Advanced Solid Tumors
A Study Evaluating the Pharmacokinetics of S-1 in patients with impaired renal function
Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals
Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals
A Phase I Investigation of the Safety, Tolerability and Immunogenicity of V934/V935 hTERT Vaccination in Cancer Patients With Selected Solid Tumors
Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals
Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals
Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals
A Phase 1b Trial of the Combination of Bryostatin-1 and Low Dose Interleukin-2: Evaluation of the Functional and Molecular Status of Human Monocytes as Antigen Presenting cells
Phase I study of I-131-CLR1404 in patients with Relapsed or Refractory Advanced Solid Tumors
An open-label dose escalation study of patients with solid tumors treated with STA-9090
An open-label dose escalation study of patients with solid tumors treated with STA-9090
An open-label dose escalation study of patients with solid tumors treated with STA-9090
An open-label dose escalation study of patients with solid tumors treated with STA-9090
Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals
Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals
Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals
Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals
Phase I study of I-131-CLR1404 in patients with Relapsed or Refractory Advanced Solid Tumors
(ADVL0714) A Phase I Study of VEGF Trap in Children with Refractory Solid Tumors
(ADVL0812) A Phase I Study of MLN8237, an Oral Selective Small Molecule Inhibitor of Aurora A Kinase, in Children with Relapsed/Refractory Solid Tumors and Leukemia
ADVL0612: A Phase I Study of Sunitinib (SU11248), an Oral Multi-Targeted Tyrosine Kinase Inhibitor, in Children with Refractory Solid Tumors
ADVL0815: A Phase I Study of Pazopanib as a Single Agent for Children with Refractory Solid Tumors
ADVL0816: A Phase I Study of Obatoclax (Pan Anti-Apoptotic BCL-2 Family Small Molecule Inhibitor), in Combination with Vincristine/Doxorubicin/Dexrazoxane, in Children with Relapsed/Refractory Solid Tumors or Leukemia
Phase I Study of the RAF Kinase and Receptor Tyrosine Kinase Inhibitor Sorafenib in Children with Refractory Solid Tumors or Refractory Leukemias
VITAC: A Pilot Study of the Addition of Bevacizumab to Vincristine, Oral Irinotecan and Temozolomide (VOIT regiment) for Relapsed/Refractory Pediatric Solid Tumors
A Phase 1 Study of STA-9090, Administered Once-Weekly in Patients with Solid Tumors
A Phase I Investigation of the Safety, Tolerability and Immunogenicity of V934/V935 hTERT Vaccination in Cancer Patients With Selected Solid Tumors
Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals
A Phase I Investigation of the Safety, Tolerability and Immunogenicity of V934/V935 hTERT Vaccination in Cancer Patients With Selected Solid Tumors
Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals
Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals
Phase I study of I-131-CLR1404 in patients with Relapsed or Refractory Advanced Solid Tumors
Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals
Study to evaluate the clinical benefit response of a new drug AMT vs Placebo in advanced cancer patients with esophagus, colon, pancreas, lung, gastric, liver, gall bladder, prostate and female reproductive system cancers
